Phase I trial of belinostat with cisplatin and etoposide in advanced solid tumors, with a focus on neuroendocrine and small cell cancers of the lung-Reference-Cited by-同舟云学术

Phase I trial of belinostat with cisplatin and etoposide in advanced solid tumors, with a focus on neuroendocrine and small cell cancers of the lung

Published:2018-06 Issue:5 Volume:29 Page:457-465
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Balasubramaniam Sanjeeve,Redon Christophe E.,Peer Cody J.,Bryla Christine,Lee Min-Jung,Trepel Jane B.,Tomita Yusuke,Rajan Arun,Giaccone Giuseppe,Bonner William M.,Figg William D.,Fojo Tito,Piekarz Richard L.,Bates Susan E.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference39 articles.

1. Selecting patients with extensive-stage small cell lung cancer for prophylactic cranial irradiation by predicting brain metastases;Greenspoon;J Thorac Oncol,2011

2. A comprehensive review of poorly differentiated neuroendocrine carcinomas (pdNECs): a niche to find novel opportunities;Reguera;Curr Pharm Des,2014

3. Antiproliferative effects of the histone deacetylase inhibitor FR901228 on small-cell lung cancer lines and drug-resistant sublines;Tsurutani;Int J Cancer,2003

4. The HDAC inhibitor trichostatin A inhibits growth of small cell lung cancer cells;Platta;J Surg Res,2007

5. Valproic acid induces Notch1 signaling in small cell lung cancer cells;Platta;J Surg Res,2008

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small cell lung cancer: emerging subtypes, signaling pathways, and therapeutic vulnerabilities;Experimental Hematology & Oncology;2024-08-05

2. Successful treatment with tislelizumab plus chemotherapy for SMARCA4-deficient undifferentiated tumor: a case report;Frontiers in Immunology;2024-05-31

3. Entinostat in patients with relapsed or refractory abdominal neuroendocrine tumors;The Oncologist;2024-05-31

4. Pancreatic Neuroendocrine Tumors: Signaling Pathways and Epigenetic Regulation;International Journal of Molecular Sciences;2024-01-22

5. Machine learning in onco-pharmacogenomics: a path to precision medicine with many challenges;Frontiers in Pharmacology;2024-01-09